Insulet
PODD
582 hedge funds and large institutions have $23.3B invested in Insulet in 2023 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 223 increasing their positions, 176 reducing their positions, and 42 closing their positions.
155% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 42
27% more repeat investments, than reductions
Existing positions increased: 223 | Existing positions reduced: 176
15% more call options, than puts
Call options by funds: $112M | Put options by funds: $97.5M
13% more capital invested
Capital invested by funds: $20.6B → $23.3B (+$2.66B)
11% more funds holding
Funds holding: 525 → 582 (+57)
3.88% more ownership
Funds ownership: 100.97% → 104.85% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$409M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$408M |
| 3 |
BlackRock
New York
|
+$330M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$157M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$118M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$247M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$233M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$175M |
| 4 |
DCP
D1 Capital Partners
New York
|
-$158M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$141M |
PODD Hedge Fund Activity: Q1 2023 in Review
582 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2023, worth a combined $23.3B — up 13% from $20.6B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new PODD positions and 42 closed out — a net gain of 65 holders — while 223 added to existing stakes and 176 trimmed.
The largest buyer was State Street, adding an estimated $409M. The largest seller was T. Rowe Price Associates, cutting an estimated $247M.
- 582 institutional investors held Insulet (PODD) as of Q1 2023, up from 525 in Q4 2022.
- Funds reported $23.3B of Insulet stock for Q1 2023, up 13% quarter-over-quarter.
- 107 funds opened new Insulet positions in Q1 2023 and 42 closed out, a net change of +65 holders.
- The largest Insulet buyer in Q1 2023 was State Street, an estimated $409M added.
- The largest Insulet seller in Q1 2023 was T. Rowe Price Associates, an estimated $247M sold.
Based on aggregated 13F filings for Q1 2023.